Background Acute hypoxaemic respiratory failure (AHRF) and mostly acute respiratory
distress syndrome (ARDS) are critical conditions. AHRF results from several systemic …

It has been known for more than 60 years, and suspected for over 100, that alveolar hypoxia
causes pulmonary vasoconstriction by means of mechanisms local to the lung. For the last …

A randomized, controlled clinical trial was performed with patients with acute respiratory
distress syndrome (ARDS) to compare the effect of conventional therapy or inhaled nitric …

Objective To determine possible changes in outcome from acute respiratory distress
syndrome (ARDS) and to compare severity of lung injury and methods of treatment from …

Inhaled nitric oxide (NO) improves systemic oxygenation (PaO2/FIO2) in adult patients with
acute respiratory distress syndrome (ARDS). However, individual response varies, and …

The past decade has witnessed an explosion in the interest of biologists in the gas nitric
oxide (NO). This highly reactive free radical, first considered only a noxious air pollutant, is …

The discovery within the paranasal sinuses for the production of nitric oxide (NO) has altered
the traditional explanations of sinus physiology. This review article reports the ongoing …

Nitric oxide (NO), an atmospheric gas and free radical, is also an important biological
mediator in animals and humans. Its enzymatic synthesis by constitutive (c) and inducible (i) …

Background Nitric oxide inhibits platelet adhesion and aggregation in vitro. The aim of this
prospective study was to assess the platelet antiaggregating activity of nitric oxide …

Phenylephrine is a direct-acting, predominantly α1 adrenergic receptor agonist used by
anesthesiologists and intensivists to treat hypotension. A variety of physiologic studies …